Equities

Inspira Technologies Oxy BHN Ltd

IINN:NAQ

Inspira Technologies Oxy BHN Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.36
  • Today's Change0.01 / 0.74%
  • Shares traded174.60k
  • 1 Year change+17.24%
  • Beta2.0927
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast

The one analyst offering a 12 month price target expects Inspira Technologies Oxy BHN Ltd share price to rise to 13.00 in the next year from the last price of 1.35.
High863.0%13.00
Med863.0%13.00
Low863.0%13.00

Earnings history & estimates in USD

On Mar 25, 2024, Inspira Technologies Oxy BHN Ltd reported 4th quarter 2023 losses of -0.17 per share. This result exceeded the -0.29 consensus loss of the one analyst covering the company and under-performed last year's 4th quarter results by -0.136.
Average growth rate-170.24%
Inspira Technologies Oxy BHN Ltd reported annual 2023 losses of -0.93 per share on Mar 25, 2024.
Average growth rate+36.21%
More ▼

Revenue history & estimates in USD

Inspira Technologies Oxy BHN Ltd did not report revenues for the full year 2023. However, during the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.